Peresolimab, a humanized IgG1 monoclonal antibody treatment for rheumatoid arthritis, shows promising results in phase 2a trial
According to a phase 2a study published in New England Journal of Medicine, peresolimab has shown effectiveness in rheumatoid arthritis (RA) patients. Peresolimab is a …